# Maternal Poly (I:C)-Induced Placental Inflammation and Endocrine Dysfunction Are Associated with Disrupted Corticogenesis in Mouse Offspring

**Authors:** Catherine Zhou, Callan Baldwin, Shuying Lin, Aaron Hayes, Kathleen Carter, Lir-Wan Fan, Abhay Bhatt, Yi Pang

PMC · DOI: 10.3390/brainsci16020126 · Brain Sciences · 2026-01-24

## TL;DR

Maternal inflammation during pregnancy disrupts placental function and leads to abnormal brain development in mouse offspring, potentially contributing to autism-like behaviors.

## Contribution

This study identifies placental inflammation and endocrine dysfunction as key mechanisms linking maternal immune activation to disrupted neurogenesis in offspring.

## Key findings

- Maternal poly(I:C) exposure increases placental monocytes and neutrophils, along with inflammatory cytokines.
- Reduced placental NGF levels and sustained microglial activation are observed in offspring brains.
- Altered cortical neurogenesis includes increased early-born and later-born neurons in offspring.

## Abstract

Background/Objectives: Maternal immune activation (MIA) increases the risk of Autism Spectrum Disorders (ASD). Experimental models demonstrate that maternal exposure to bacterial endotoxin or the viral mimic polyinosinic:polycytidylic acid [poly (I:C)] reliably recapitulates ASD-like behavioral abnormalities in offspring, yet the underlying neurobiological mechanisms linking MIA to altered neurodevelopment remain incompletely understood. Increasing evidence highlights the placenta as a critical mediator in shaping fetal brain development through immunological and hormonal regulation. Likewise, disruption of placental regulatory functions upon MIA may therefore represent a mechanistic pathway. Here, we investigated how alterations in placental cytokine profiles, innate immune cell composition, and endocrine outputs relate to neuroinflammation and neurogenesis in the offspring. Methods: Pregnant mice at gestational day 12.5 received a single intraperitoneal injection of poly (I:C). Placental macrophages, neutrophils, inflammatory cytokines, and nerve growth factor (NGF) expression were examined 72 h later. Neurodevelopmental outcomes, including microglial activity and neurogenic markers, were evaluated in mouse offspring at postnatal day (P) 1 and 6. Results: MIA induced a significant accumulation of monocytes and neutrophils in the placenta, which was associated with elevated levels of a broad spectrum of inflammatory mediators, including Th17-biased proinflammatory cytokines, chemokines, and adhesion proteins, in the placenta and amniotic fluid. In contrast, the placenta-derived NGF levels were significantly reduced. MIA induced strong and sustained microglial activation in the fetal and neonatal brain. This inflammatory milieu was accompanied by disrupted cortical neurogenesis, characterized by a marked increase in Ki67+ neuronal progenitor cells (NPCs) in the subventricular zone (SVZ), overproduction of early-born Tbr1+ neurons at P1, later-born Satb2+ neurons at P6. Conclusions: Collectively, these findings suggest that heightened Th17 inflammatory signaling, coupled with impaired placental endocrine function, contributes to dysregulated cortical neurogenesis in the offspring.

## Linked entities

- **Proteins:** NGF (nerve growth factor), Mki67 (antigen identified by monoclonal antibody Ki 67), TBR1 (T-box brain transcription factor 1), SATB2 (SATB homeobox 2)
- **Chemicals:** poly (I:C) (PubChem CID 135618150)
- **Diseases:** ASD (MONDO:0006664)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, Ngf (nerve growth factor) [NCBI Gene 18049] {aka Ngfb, beta-NGF}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Ntf3 (neurotrophin 3) [NCBI Gene 18205] {aka HDNF, NGF-2, Nt3, Ntf-3}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 8836] {aka GATD10, GH}, Eda (ectodysplasin-A) [NCBI Gene 13607] {aka EDA1, Ed1, Eda-A1, Eda-A2, HED, Ta}, Tbr1 (T-box brain transcription factor 1) [NCBI Gene 21375], Tlr3 (toll-like receptor 3) [NCBI Gene 142980], Mia (MIA SH3 domain containing) [NCBI Gene 12587] {aka CD-RAP, Cdrap, Mia1}, Bcl11b (B cell leukemia/lymphoma 11B) [NCBI Gene 58208] {aka 9130430L19Rik, B630002E05Rik, BCL-11B, Ctip2, Rit1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, Dcx (doublecortin) [NCBI Gene 13193] {aka Dbct}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Satb2 (special AT-rich sequence binding protein 2) [NCBI Gene 212712] {aka BAP002, mKIAA1034}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** cognitive impairment (MESH:D003072), NPC (MESH:D052556), chorioamnionitis (MESH:D002821), neurodevelopmental disorders (MESH:D002658), neurodevelopmental disabilities (MESH:D007859), inflammatory cytokines (MESH:D000080424), preeclampsia (MESH:D011225), neuroinflammation (MESH:D000090862), impairments in (MESH:D060825), behavioral abnormalities (MESH:D001523), infection (MESH:D007239), eclampsia (MESH:D004461), placental (MESH:D010922), Endocrine Dysfunction (MESH:D004700), intellectual disability (MESH:D008607), ASD (MESH:D000067877), injury to (MESH:D014947), poor (MESH:D009123), Inflammation (MESH:D007249), IUGR (MESH:D005317)
- **Chemicals:** serotonin (MESH:D012701), DAPI (MESH:C007293), Tween-20 (MESH:D011136), Alexa Fluor 555 (MESH:C000608607), SDS (MESH:D012967), LPS (MESH:D008070), PFA (MESH:C003043), sucrose (MESH:D013395), isoflurane (MESH:D007530), Na4P2O7 (MESH:C107241), NaF (MESH:D012969), water (MESH:D014867), citrate (MESH:D019343), EGTA (MESH:D004533), Triton X-100 (MESH:D017830), Alexa Fluor 488 (MESH:C000711379), EDTA (MESH:D004492), Poly (I:C) (MESH:D011070), glycerol (MESH:D005990), Na3VO4 (-), NaCl (MESH:D012965), sodium deoxycholate (MESH:D003840)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937977/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937977/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937977/full.md

---
Source: https://tomesphere.com/paper/PMC12937977